论文部分内容阅读
现代生物药业的发展已经历了两次浪潮,随着人类基因组测序的完成以及基因组后功能研究的开展,以基因组医药(Genomic Medicine)为特征的生物药业的第三次浪潮,将会给人类的医药保健事业带来革命性的变化。重组蛋白质的成功开发——生物药业的第一次浪潮重组生物药业是在二十世纪六七十年代建立的重组DNA技术和重组蛋白质大规模表达,纯化技术的基础上
The development of modern biopharmaceuticals has experienced two waves. With the completion of human genome sequencing and the development of post-genomic functional studies, the third wave of biopharmaceuticals featuring Genomic Medicine will be given. The revolution in human health and medical care has brought about revolutionary changes. The successful development of recombinant proteins—the first wave of biopharmaceuticals The recombinant biopharmaceutical industry was based on the recombinant DNA technology and the large-scale expression and purification technology of recombinant proteins established in the 1960s and 1970s.